申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210070698A1
公开(公告)日:2021-03-11
The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed.